Abraham Silji 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed May 2, 2023
Insider Transaction Report
Form 4
Abraham Silji
Chief Digital & Trans Officer
Transactions
- Sale
Common Stock
2023-05-01$366.14/sh−649$237,624→ 4,209.3 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-05-01−8,020→ 0 totalExercise: $86.24From: 2019-02-26Exp: 2028-02-26→ Common Stock (8,020 underlying) - Exercise/Conversion
Common Stock
2023-05-01$86.24/sh+8,020$691,645→ 12,229.3 total - Sale
Common Stock
2023-05-01$365.55/sh−7,371$2,694,493→ 4,858.3 total
Footnotes (3)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.91, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $366.0350 to $366.18, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]This award vests in 4 equal annual installments beginning on 2/26/2019.